J9177 HCPCS code: Injection, enfortumab vedotin-ejfv, 0.25 mg
J9177 is the HCPCS Level II code for injection, enfortumab vedotin-ejfv, 0.25 mg. In 2024 Medicare paid an average of $28.48 per service for J9177 across 6,019,150 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 520 per day on outpatient hospital claims. Medicare volume rose 203% from 2022 to 2024 (1,988,851 to 6,019,150 services). In 2024, about 2,239 clinicians billed Medicare for J9177 for 1,961 beneficiaries; Florida, Texas, California accounted for 36% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2020-07-01 |
| Last action effective | 2020-07-01 |
Who bills J9177 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,239 |
| Medicare beneficiaries | 1,961 |
| States with claims | 32 |
| Share of services in top 3 states (Florida, Texas, California) | 36% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9177, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,988,851 | 642 | $30.77 | $24.58 |
| 2023 | 3,114,236 | 1,132 | $33.32 | $26.69 |
| 2024 | 6,019,150 | 1,961 | $35.31 | $28.48 |
States with the most J9177 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 882,496 | $28.53 |
| Texas | 640,256 | $28.44 |
| California | 553,482 | $28.37 |
| Arizona | 280,164 | $28.64 |
| Virginia | 266,816 | $28.53 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 520 | CMS Policy |
| practitioner claims | 520 | CMS Policy |
What changed for J9177
- 2020-07-01: J9177 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9177?
J9177 is the HCPCS Level II code for injection, enfortumab vedotin-ejfv, 0.25 mg. Short descriptor: "Inj enfort vedo-ejfv 0.25mg".
How much does Medicare pay for J9177?
In 2024, the average Medicare payment was $28.48 per service (average allowed $35.31).
Does Medicare cover J9177?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9177 can be billed per day?
520 on outpatient hospital claims; 520 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9177
- Watch J9177 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9177
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.